Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Natural killer T cells in bronchial biopsies from human allergen challenge model of allergic asthma.

Reynolds C, Barkans J, Clark P, Kariyawasam H, Altmann D, Kay B, Boyton R.

J Allergy Clin Immunol. 2009 Oct;124(4):860-2; author reply 862. doi: 10.1016/j.jaci.2009.07.022. Epub 2009 Sep 19. No abstract available.

PMID:
19767076
2.

Activin and transforming growth factor-beta signaling pathways are activated after allergen challenge in mild asthma.

Kariyawasam HH, Pegorier S, Barkans J, Xanthou G, Aizen M, Ying S, Kay AB, Lloyd CM, Robinson DS.

J Allergy Clin Immunol. 2009 Sep;124(3):454-62. doi: 10.1016/j.jaci.2009.06.022.

3.

Basal expression of bone morphogenetic protein receptor is reduced in mild asthma.

Kariyawasam HH, Xanthou G, Barkans J, Aizen M, Kay AB, Robinson DS.

Am J Respir Crit Care Med. 2008 May 15;177(10):1074-81. doi: 10.1164/rccm.200709-1376OC. Epub 2008 Feb 21.

PMID:
18292470
4.

Skin reactivity and local cell recruitment in human atopic and nonatopic subjects by CCL2/MCP-1 and CCL3/MIP-1alpha.

Gaga M, Ong YE, Benyahia F, Aizen M, Barkans J, Kay AB.

Allergy. 2008 Jun;63(6):703-11. Epub 2007 Dec 6.

PMID:
18070228
5.

Remodeling and airway hyperresponsiveness but not cellular inflammation persist after allergen challenge in asthma.

Kariyawasam HH, Aizen M, Barkans J, Robinson DS, Kay AB.

Am J Respir Crit Care Med. 2007 May 1;175(9):896-904. Epub 2007 Feb 1.

PMID:
17272787
6.

Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge.

Ong YE, Menzies-Gow A, Barkans J, Benyahia F, Ou TT, Ying S, Kay AB.

J Allergy Clin Immunol. 2005 Sep;116(3):558-64.

PMID:
16159624
7.

Acute allergen-induced airway remodeling in atopic asthma.

Phipps S, Benyahia F, Ou TT, Barkans J, Robinson DS, Kay AB.

Am J Respir Cell Mol Biol. 2004 Dec;31(6):626-32. Epub 2004 Aug 27.

PMID:
15333330
8.

The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma.

Kon OM, Sihra BS, Loh LC, Barkans J, Compton CH, Barnes NC, Larché M, Kay AB.

Eur Respir J. 2001 Jul;18(1):45-52.

9.

Blood eosinophils from atopic donors express messenger RNA for the alpha, beta, and gamma subunits of the high-affinity IgE receptor (Fc epsilon RI) and intracellular, but not cell surface, alpha subunit protein.

Smith SJ, Ying S, Meng Q, Sullivan MH, Barkans J, Kon OM, Sihra B, Larché M, Levi-Schaffer F, Kay AB.

J Allergy Clin Immunol. 2000 Feb;105(2 Pt 1):309-17.

PMID:
10669852
10.

Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics.

Larché M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS.

J Immunol. 1998 Dec 1;161(11):6375-82.

11.

Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis.

Gaga M, Bentley AM, Humbert M, Barkans J, O'Brien F, Wathen CG, Kay AB, Durham SR.

Thorax. 1998 Aug;53(8):685-91.

12.

Increased expression of high affinity IgE (FcepsilonRI) receptor-alpha chain mRNA and protein-bearing eosinophils in human allergen-induced atopic asthma.

Rajakulasingam K, Till S, Ying S, Humbert M, Barkans J, Sullivan M, Meng Q, Corrigan CJ, Bungre J, Grant JA, Kay AB, Durham SR.

Am J Respir Crit Care Med. 1998 Jul;158(1):233-40.

PMID:
9655735
14.

IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects.

Barata LT, Ying S, Meng Q, Barkans J, Rajakulasingam K, Durham SR, Kay AB.

J Allergy Clin Immunol. 1998 Feb;101(2 Pt 1):222-30.

PMID:
9500756
15.

Allergen-induced recruitment of Fc epsilon RI+ eosinophils in human atopic skin.

Barata LT, Ying S, Grant JA, Humbert M, Barkans J, Meng Q, Durham SR, Kay AB.

Eur J Immunol. 1997 May;27(5):1236-41.

PMID:
9174616
16.

Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics.

Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, Larché M, Robinson DS, Durham SR, Kay AB.

J Immunol. 1997 Apr 1;158(7):3539-44.

PMID:
9120316
17.

RANTES in human allergen-induced rhinitis: cellular source and relation to tissue eosinophilia.

Rajakulasingam K, Hamid Q, O'Brien F, Shotman E, Jose PJ, Williams TJ, Jacobson M, Barkans J, Durham SR.

Am J Respir Crit Care Med. 1997 Feb;155(2):696-703.

PMID:
9032215
18.
19.

IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.

Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, Pfister R, Menz G, Robinson DS, Kay AB, Corrigan CJ.

Am J Respir Crit Care Med. 1996 Nov;154(5):1497-504.

PMID:
8912771
20.

High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma.

Humbert M, Grant JA, Taborda-Barata L, Durham SR, Pfister R, Menz G, Barkans J, Ying S, Kay AB.

Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1931-7.

PMID:
8665058
21.

Identification of interleukin-2 in human peripheral blood eosinophils.

Levi-Schaffer F, Barkans J, Newman TM, Ying S, Wakelin M, Hohenstein R, Barak V, Lacy P, Kay AB, Moqbel R.

Immunology. 1996 Jan;87(1):155-61.

22.

Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein.

Ying S, Meng Q, Taborda-Barata L, Corrigan CJ, Barkans J, Assoufi B, Moqbel R, Durham SR, Kay AB.

Eur J Immunol. 1996 Jan;26(1):70-6.

PMID:
8566086
23.

Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product.

Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, Taborda-Barata L, Meng Q, Corrigan CJ, Durham SR, Kay AB.

J Immunol. 1995 Nov 15;155(10):4939-47.

PMID:
7594499
25.

Serum interleukin 5 concentrations in atopic and non-atopic patients with glucocorticoid-dependent chronic severe asthma.

Alexander AG, Barkans J, Moqbel R, Barnes NC, Kay AB, Corrigan CJ.

Thorax. 1994 Dec;49(12):1231-3.

26.

Kinetics of cell infiltration and cytokine messenger RNA expression after intradermal challenge with allergen and tuberculin in the same atopic individuals.

Tsicopoulos A, Hamid Q, Haczku A, Jacobson MR, Durham SR, North J, Barkans J, Corrigan CJ, Meng Q, Moqbel R, et al.

J Allergy Clin Immunol. 1994 Oct;94(4):764-72.

PMID:
7930311
27.

T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis.

Ying S, Durham SR, Barkans J, Masuyama K, Jacobson M, Rak S, Löwhagen O, Moqbel R, Kay AB, Hamid QA.

Am J Respir Cell Mol Biol. 1993 Oct;9(4):356-60.

PMID:
8398174
28.

Chronic hyperplastic sinusitis: association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3.

Hamilos DL, Leung DY, Wood R, Meyers A, Stephens JK, Barkans J, Meng Q, Cunningham L, Bean DK, Kay AB, et al.

J Allergy Clin Immunol. 1993 Jul;92(1 Pt 1):39-48.

PMID:
8335853
29.

Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro.

Sehmi R, Walsh GM, Hartnell A, Barkans J, North J, Kay AB, Moqbel R.

Pediatr Allergy Immunol. 1993;4(4 Suppl):13-8. Review. No abstract available.

PMID:
8353654
31.

Human eosinophils synthesize and secrete interleukin-6, in vitro.

Hamid Q, Barkans J, Meng Q, Ying S, Abrams JS, Kay AB, Moqbel R.

Blood. 1992 Sep 15;80(6):1496-501.

PMID:
1520876
32.

Co-expression of CD25 and CD3 in atopic allergy and asthma.

Hamid Q, Barkans J, Robinson DS, Durham SR, Kay AB.

Immunology. 1992 Apr;75(4):659-63.

33.

Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells.

Bentley AM, Jacobson MR, Cumberworth V, Barkans JR, Moqbel R, Schwartz LB, Irani AM, Kay AB, Durham SR.

J Allergy Clin Immunol. 1992 Apr;89(4):877-83.

PMID:
1532808
35.

Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma.

Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB.

N Engl J Med. 1992 Jan 30;326(5):298-304.

36.

Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils.

Moqbel R, Hamid Q, Ying S, Barkans J, Hartnell A, Tsicopoulos A, Wardlaw AJ, Kay AB.

J Exp Med. 1991 Sep 1;174(3):749-52.

37.

T lymphocytes and eosinophils in allergen-induced late-phase asthmatic reactions in the guinea pig.

Frew AJ, Moqbel R, Azzawi M, Hartnell A, Barkans J, Jeffery PK, Kay AB, Scheper RJ, Varley J, Church MK, et al.

Am Rev Respir Dis. 1990 Feb;141(2):407-13.

PMID:
2137315
38.

Development of anti-idiotypic antibodies against tumour antigens and autoantigens in ovarian cancer patients treated intraperitoneally with mouse monoclonal antibodies.

Courtenay-Luck NS, Epenetos AA, Sivolapenko GB, Larche M, Barkans JR, Ritter MA.

Lancet. 1988 Oct 15;2(8616):894-7.

PMID:
2902328
39.

Monoclonal antibodies to human eosinophil plasma membrane antigens enhance the secretion of eosinophil cationic protein.

Tai PC, Capron M, Bakes DM, Barkans J, Spry CJ.

Clin Exp Immunol. 1986 Mar;63(3):728-37.

40.

Plasma membrane antigens on light density and activated human blood eosinophils.

Tai PC, Bakes DM, Barkans JR, Spry CJ.

Clin Exp Immunol. 1985 May;60(2):427-36.

41.

Tissue localization of human eosinophil cationic proteins in allergic diseases.

Spry CJ, Tai PC, Barkans J.

Int Arch Allergy Appl Immunol. 1985;77(1-2):252-4.

PMID:
4008081
42.

Eosinophil membrane antigens: phenotypic frequencies in normal individuals and patients with the hypereosinophilic syndrome.

Tai PC, Spry CJ, Bakes DM, Barkans JR.

Int Arch Allergy Appl Immunol. 1985;77(1-2):249-51.

PMID:
4008080

Supplemental Content

Loading ...
Support Center